#liver cancer

Opdivo Immunotherapy Improves Survival for People With Liver Cancer

October is Liver Cancer Awareness Month.

Engineered T cells prevent recurrence over five years.

The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.

Adding internal radiation or TACE did appear to help certain people, however.

This is according to a recent mathematical modeling study.

Liver cancer development is strongly associated with hep B.

Hepatitis B and C are declining as causes of liver cancer and liver transplants.

Recommendations now include multiple systemic medications in addition to surgery and local therapies.

Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.

Study shows VEGF inhibitor is effective for patients with a biomarker of poor prognosis.

Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.

Previous research indicated that compared with interferon-based treatment, direct-acting antiviral treatment raised this risk.

Controversial ruling relates to a chemical produced in the roasting process.

Liver cancer is a growing problem worldwide but new treatments show promise.

Retrovirus conference includes news on liver cancer and statins for cancer prevention.

Use of drugs like Nexium or Prilosec is tied to progression to cirrhosis, decompensated cirrhosis and liver cancer in this population.